SpecificationsOrganism/cell line/tissue*Human*/*MDA-MB-231*(*ATCC*)/*Breast*Sex*Female*Sequencer or array type*Illumina NextSeq 500*Data format*Raw fastq and processed bigwig files*Experimental factors*N*/*A*Experimental features*ChIP-seq analysis*Consent*N*/*A*Sample source location*N*/*A*

1. Direct link to deposited data {#s0005}
================================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=mvwzocmmtlshxcp&acc=GSE76116>

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Cell culture {#s0015}
-----------------

Human breast cancer cells (MDA-MB-231) were obtained from the American Type Culture Collection (ATCC) and maintained in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) at 37 °C in a 5% CO~2~ atmosphere.

2.2. Cell fixation {#s0020}
------------------

Sub-confluent MDA-MB-231 cells (two 15 cm dishes, treated separately) were washed twice with PBS, trypsinized, collected by centrifugation and washed once again with PBS. Cells were resuspended in 10 mL of 1% formaldehyde-PBS and incubated with constant inversion for 10 min at room temperature. To terminate fixation, 2 mL of 2 M Glycine was added to the solution and incubated for another 5 min at room temperature. Cells were divided into 3 tubes, washed twice with ice-cold PBS and stored at − 80 °C until use.

2.3. Chromatin immunoprecipitation {#s0025}
----------------------------------

To perform high quality ChIP-seq, we introduced two major modifications to a standard ChIP/ChIP-seq protocol [@bb0005]. First, we omitted sodium dodecyl sulfate (SDS) from all procedures because SDS can compromise the antibody-target protein interaction. Second, we incorporated a micrococcal nuclease (MNase) digestion step prior to chromatin fragmentation to maximize protein extraction efficiency. Detailed procedures are described below.

Fixed cells were thawed on ice and resuspended in 1 mL of ice-cold TM2 (10 mM Tris, pH 7.4, 2 mM MgCl~2~) supplemented with 0.6% NP-40 and protease inhibitor [@bb0010]. After 10 min incubation on ice, cells were washed once with ice-cold TM2 and resuspended in MNase digestion buffer (TM2 supplemented with 2 mM CaCl~2~, protease inhibitor, and 4 U MNase). After thorough mixing, cells were digested at 37 °C for 3 min and then immediately placed on ice. To stop MNase digestion, 20 μL of 0.5 M EDTA was added. After 10 min incubation on ice, cells were centrifuged and resuspended in 1 mL of fragmentation buffer (TM2 supplemented with 600 mM NaCl, 1% Triton-100, 0.1% sodium deoxycholate, and protease inhibitor) and incubated on ice for 20 min. Then, cells were fragmented using focused-ultrasonication (Covaris) under the following conditions: 12 × 12 mm round-bottom glass tube (cap with AFA fiber), Duty Cycle 20%, Peak incident Power 145 Watts, cycles per burst 200, time 15 min, Bath Temperature 4 °C. The unsoluble fraction was removed by centrifugation and supernatant was collected as the chromatin fraction. The NaCl concentration was adjusted to 150 mM by adding TM2 supplemented with protease inhibitor. After 5 min incubation on ice, any unsoluble proteins were removed by centrifugation. Chromatin (600 μL) was incubated with 3 μg of anti-MBD3 antibody (Abcam, ab91458) at 4 °C for 16 h. After adding 15 μL of blocked Dynabeads protein A/G, chromatin fraction was further incubated at 4 °C for 1.5 h. Beads were washed three times with SDS-free RIPA buffer (25 mM Tris--HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate), three times with SDS-free high salt RIPA buffer (25 mM Tris--HCl, pH 7.4, 600 mM NaCl, 1% NP-40, 1% sodium deoxycholate), and once with EB (10 mM Tris, pH 7.4).

2.4. Library preparation and sequencing {#s0030}
---------------------------------------

Washed beads were resuspended with Transposase buffer (20 μL of 1 × tagmentation buffer, 10 μL of Nextera XT transposase, 10 μL of EB) and incubated at 37 °C for 30 min. Beads were washed twice with SDS-free RIPA buffer, resuspended in 200 μL of SDS-free RIPA buffer, and incubated at 65 °C for 45 min. Samples were then treated with proteinase K, and the DNA was purified using DNA Clean & Concentrato-5 (Zymo Research) and eluted in 28 μL resuspension buffer. DNA was amplified and purified using standard NexteraXT PCR conditions without any modifications. The resulting libraries were sequenced on the Illumina NextSeq 500 paired-end system at the NIEHS Epigenomics Core Facility.

2.5. Sequencing data processing for quality control {#s0035}
---------------------------------------------------

Sequencing reads were quality filtered, adapter trimmed, and mapped to human reference genome (UCSC assembly hg19, GRCh37) using Bowtie (version 0.12.8) [@bb0015]. The non-duplicate uniquely mapped reads were selected with the Picard tool (<http://picard.sourceforge.net>) and used for subsequent analysis. Basic quality control data are provided in [Table 1](#t0005){ref-type="table"}. To make coverage tracks, the paired-end reads were merged into single fragments and converted to bigwig files. An example locus showing MBD3 enrichment is depicted in genome browser format ([Fig. 1](#f0005){ref-type="fig"}).
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![An example in UCSC genome browser format. MBD3 binding pattern at VCAN gene is shown (two biological replicates; MBD3 rep1 and MBD3 rep2).](gr1){#f0005}

###### 

Basic quality score for ChIP-seq data.

  Sample        Sequencing type   Raw read pairs (a)   Uniquely mapped pairs (b)   (b/a) %   Non-duplicate pairs (c)   (c/b) %
  ------------- ----------------- -------------------- --------------------------- --------- ------------------------- ---------
  Replicate 1   Paired-end        50,887,944           35,909,398                  70.57%    29,442,026                81.99%
  Replicate 2   Paired-end        74,312,781           51,458,955                  69.25%    44,711,162                86.89%
